Predictmedix AI Inc PMEDF

Primary Symbol: C.PMED

Predictmedix AI Inc. is a life sciences technology company. The Company, through its subsidiaries, focuses on artificial intelligence (AI) technologies which target two specific areas: workplace health and safety and healthcare. It has developed a technology for the identification and detection of infectious disease symptoms, including COVID-19, referred to as its infectious disease symptom screening solutions (IDSS) and marketed in North America under the name Safe Entry System. It is also developing AI-powered products that address detection of alcohol and/or cannabis impairment in individuals; mental illness screening, and remote patient monitoring and treatment plans, referred to as the Mobile Wellbeing product. It is adding additional modules to this Mobile Wellbeing platform that enable us to use a patient’s history and real-time medical data, such as blood pressure, and to provide patients and their medical professionals with treatment plans for chronic disease management.

CSE:PMED - Post by User

Predictmedix AI Inc > Preparing for the Next Stages of COVID-19 and Impairment

<< Previous

Bullboard Posts

Next >>

Post by chrispion Oct 20, 2021 8:36am

235 Views

Post# 34026066

Preparing for the Next Stages of COVID-19 and Impairment

Great overview article: redictmedix: Preparing for the Next Stages of COVID-19 and Impairment Challenges in the Workplace

October 20, 2021 - Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF)

Reliable, quick, contactless, cost-effective screening solutions to bring safety to your workplace.

Preparing for the Next Stages of COVID-19 and Impairment Challenges in the Workplace

Safe Entry Stations

Mitigate risks to your team and to the uninterrupted operation of your business by setting up Safe Entry Stations for infectious disease symptom detection or for impairment detection. Our screening products are quick, noninvasive, no-contact solutions that can detect indication of symptoms.

All it takes is a simple walk-through.

Safe Entry Station featured on Global News TV

(Oct 13/2021)

WATCH GLOBAL NEWS STORY

“Implementing Safe Entry at our plants has dramatically decreased our absenteeism and increased employee peace of mind. Keeping our staff safe is top priority, and as such, we were determined to implement the best available solution, which we found in Safe Entry.”

- Nicholas Reichenbach, Founder & Executive Chairman, Flow Water Inc.

Designed by infectious disease experts, medical doctors, impairment specialists, and a global team of data scientists, and using a vast collection of continually updated real-world data, Predictmedix’s patent-pending screening is entirely autonomous and designed to protect the privacy of the end-user.

“The most interesting part is that Predictmedix focuses on AI solutions to problems that matter to all of us.”

- Kapil Raval, Advisor at Predictmedix,
Director of Artificial Intelligence Business Development, Microsoft

Partnered With

Safe Entry Stations are currently operating at many companies and events around the world.

Adopted By:

Completely unique to other solutions on the market, Predictmedix’s leading technology is changing the way we look at mass screening for infectious diseases and impairment. Safe Entry’s autonomous, comprehensive analysis provides peace of mind to individuals and businesses wherever people are entering shared spaces, be it for work or entertainment.

READ THE LATEST NEWS

See How Safe Entry Works

Learn how the Safe Entry Station comprehensively screens without any contact.

Watch video of SAFE ENTRY STATION

DOWNLOAD PDF PRESENTATION

About Predictmedix

Predictmedix (CSE:PMED) (OTCQB:PMEDF) is an emerging provider of rapid health screening and remote patient care solutions globally. The Company’s Safe Entry Stations – powered by a proprietary artificial intelligence (AI) – use multispectral cameras to analyze physiological data patterns and predict a variety of health issues. The Company’s current product is able to screen for infectious diseases such as COVID-19, while its technology under development will screen for impairment by drugs or alcohol, or various mental illnesses. Predictmedix’s proprietary remote patient care platform under development will empower medical professionals with a suite of AI-powered tools to improve patient health outcomes. To learn more, please visit our website at www.Predictmedix.com or follow us on Twitter, Instagram or LinkedIn.